MARALIXIBAT CHLORIDE

MARALIXIBAT CHLORIDE was reported 1002 times

MARALIXIBAT CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BILE ACIDS ABNORMAL 8 0.3636
1 BILE ACIDS INCREASED 53 0.2994
2 ALAGILLE SYNDROME 3 0.2308
3 PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS 1 0.0714
4 LIPOPROTEIN ABNORMAL 1 0.0667
5 PIERCING ASSOCIATED COMPLICATION 1 0.0556
6 VITAMIN E DEFICIENCY 2 0.0500
7 RENAL AND LIVER TRANSPLANT 1 0.0500
8 TOTAL BILE ACIDS INCREASED 7 0.0479
9 DUODENAL VARICES 1 0.0417
10 XANTHOMA 8 0.0396
11 FEMORAL ANTEVERSION 1 0.0323
12 NEONATAL DYSPNOEA 3 0.0316
13 CHOLESTATIC PRURITUS 1 0.0312
14 LIVER TRANSPLANT 103 0.0283
15 TRANSPLANT EVALUATION 14 0.0276
16 BILIARY TRACT OPERATION 2 0.0230
17 VITAMIN A INCREASED 1 0.0200
18 VITAMIN E DECREASED 1 0.0189
19 MYRINGOTOMY 1 0.0185
20 ANORECTAL MALFORMATION 1 0.0179
21 BLOOD BILIRUBIN 1 0.0149
22 CONGENITAL ABSENCE OF BILE DUCTS 1 0.0147
23 VIRAL CARDIOMYOPATHY 1 0.0127
24 ROSEOLA 1 0.0123
25 BLADDER TRABECULATION 1 0.0123
26 INTRACARDIAC PRESSURE INCREASED 1 0.0114
27 VITAMIN K DECREASED 1 0.0106
28 VITAMIN K DEFICIENCY 4 0.0100
29 VITAMIN A DEFICIENCY 1 0.0098
30 FLUID INTAKE RESTRICTION 1 0.0091
31 BILE ACID MALABSORPTION 2 0.0071
32 LIMB FRACTURE 1 0.0067
33 TEETHING 2 0.0067
34 FEEDING INTOLERANCE 3 0.0067
35 SHOULDER DYSTOCIA 1 0.0066
36 VITAMIN A DECREASED 1 0.0065
37 FAECES PALE 14 0.0063
38 GROWTH FAILURE 2 0.0058
39 MECONIUM IN AMNIOTIC FLUID 2 0.0057
40 BILIRUBIN CONJUGATED INCREASED 13 0.0056
41 ADENOIDECTOMY 2 0.0052
42 BLOOD BILIRUBIN DECREASED 3 0.0049
43 SUBCAPSULAR RENAL HAEMATOMA 1 0.0047
44 MOYAMOYA DISEASE 1 0.0046
45 ARTERIAL REPAIR 1 0.0046
46 SOFT TISSUE MASS 2 0.0043
47 BLOOD CHOLINESTERASE DECREASED 1 0.0036
48 OSTEOMYELITIS BACTERIAL 1 0.0036
49 GROIN INFECTION 2 0.0036
50 AVULSION FRACTURE 1 0.0035
51 EAR TUBE INSERTION 1 0.0034
52 NEONATAL ASPIRATION 1 0.0030
53 CHOLURIA 1 0.0029
54 VIRAL DIARRHOEA 1 0.0029
55 FAECAL OCCULT BLOOD POSITIVE 1 0.0028
56 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2 0.0028
57 FEEDING TUBE USER 1 0.0027
58 EAR OPERATION 1 0.0027
59 SPLENIC LESION 1 0.0027
60 SUICIDE THREAT 1 0.0026
61 PULMONARY ARTERY STENOSIS 1 0.0026
62 OCULAR ICTERUS 11 0.0025
63 VESICOURETERIC REFLUX 1 0.0025
64 BLOOD BILIRUBIN INCREASED 64 0.0024
65 BLOOD ALBUMIN INCREASED 2 0.0022
66 PRIMARY BILIARY CHOLANGITIS 1 0.0021
67 ELECTROLYTE DEPLETION 1 0.0020
68 HEPATIC ADENOMA 1 0.0019
69 EXPULSION OF MEDICATION 1 0.0019
70 MOLLUSCUM CONTAGIOSUM 1 0.0019
71 PORTAL HYPERTENSIVE GASTROPATHY 1 0.0018
72 VACCINATION SITE PAIN 1 0.0017
73 ROTAVIRUS INFECTION 1 0.0017
74 OESOPHAGEAL IRRITATION 1 0.0017
75 AMBLYOPIA 1 0.0017
76 JAUNDICE 44 0.0016
77 JAUNDICE NEONATAL 3 0.0016
78 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
79 SCRATCH 16 0.0015
80 HYPOVITAMINOSIS 2 0.0015
81 BRONCHITIS VIRAL 1 0.0015
82 HEPATIC FIBROSIS 5 0.0015
83 NEONATAL ASPHYXIA 1 0.0014
84 PRODUCT DISPENSING ISSUE 6 0.0014
85 NASAL INJURY 1 0.0014
86 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
87 GROWTH RETARDATION 4 0.0014
88 GASTROINTESTINAL SURGERY 1 0.0013
89 PORTAL HYPERTENSION 4 0.0013
90 GALLBLADDER POLYP 1 0.0013
91 LABORATORY TEST INTERFERENCE 1 0.0013
92 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
93 PNEUMONIA MYCOPLASMAL 1 0.0013
94 PULMONARY VALVE STENOSIS 1 0.0013
95 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
96 VACCINATION COMPLICATION 1 0.0012
97 TYMPANIC MEMBRANE PERFORATION 2 0.0012
98 EXPOSURE TO SARS-COV-2 2 0.0012
99 ADENOMA BENIGN 1 0.0012
100 HEPATIC ENZYME INCREASED 78 0.0011
101 FOOD REFUSAL 1 0.0011
102 ASPARTATE AMINOTRANSFERASE INCREASED 59 0.0011
103 LIGAMENT DISORDER 1 0.0011
104 ALANINE AMINOTRANSFERASE INCREASED 67 0.0011
105 VITAMIN D DECREASED 9 0.0011
106 PRODUCT AFTER TASTE 1 0.0010
107 INTUSSUSCEPTION 1 0.0010
108 SKIN TEXTURE ABNORMAL 1 0.0010
109 UNDERWEIGHT 2 0.0010
110 PREMATURE DELIVERY 16 0.0010
111 VARICES OESOPHAGEAL 3 0.0010
112 CHANGE OF BOWEL HABIT 2 0.0010
113 THYROID HORMONES INCREASED 1 0.0010
114 GALLBLADDER ENLARGEMENT 1 0.0009
115 CRYPTORCHISM 1 0.0009
116 MOANING 1 0.0009
117 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
118 TRANSPLANT 2 0.0008
119 FULL BLOOD COUNT INCREASED 1 0.0008
120 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
121 BILE DUCT STENOSIS 1 0.0008
122 DYSPLASIA 1 0.0008
123 PRETERM PREMATURE RUPTURE OF MEMBRANES 1 0.0008
124 FAECES SOFT 6 0.0008
125 OTITIS EXTERNA 1 0.0008
126 PRESCRIBED UNDERDOSE 16 0.0008
127 RENAL ATROPHY 1 0.0008
128 BLOOD BILIRUBIN ABNORMAL 1 0.0008
129 GESTATIONAL HYPERTENSION 1 0.0008
130 RHINOVIRUS INFECTION 3 0.0008
131 FAILURE TO THRIVE 4 0.0008
132 LIP INJURY 1 0.0008
133 STEATORRHOEA 2 0.0007
134 SKIN DEPIGMENTATION 1 0.0007
135 BLOOD PHOSPHORUS INCREASED 2 0.0007
136 ABNORMAL FAECES 6 0.0007
137 RENAL ARTERY STENOSIS 1 0.0007
138 NASAL DISCHARGE DISCOLOURATION 1 0.0007
139 DIABETIC METABOLIC DECOMPENSATION 1 0.0007
140 STREPTOCOCCAL INFECTION 4 0.0007
141 INTENSIVE CARE 1 0.0007
142 PULMONARY VALVE INCOMPETENCE 1 0.0007
143 PRURITUS 258 0.0007
144 STOMA SITE HAEMORRHAGE 1 0.0006
145 FAECES DISCOLOURED 14 0.0006
146 YELLOW SKIN 3 0.0006
147 TRANSCRIPTION MEDICATION ERROR 1 0.0006
148 SKULL FRACTURE 1 0.0006
149 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
150 EDUCATIONAL PROBLEM 1 0.0006
151 HEPATIC ENZYME ABNORMAL 3 0.0006
152 SKIN WOUND 1 0.0006
153 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
154 OTORRHOEA 1 0.0006
155 LIVER FUNCTION TEST INCREASED 12 0.0006
156 LIVER TRANSPLANT REJECTION 1 0.0006
157 NARCOLEPSY 1 0.0005
158 BLOOD BICARBONATE DECREASED 1 0.0005
159 HEPATIC MASS 1 0.0005
160 FAECES HARD 2 0.0005
161 EPIGASTRIC DISCOMFORT 2 0.0005
162 MULTI-ORGAN DISORDER 1 0.0005
163 CHOLANGITIS 3 0.0005
164 LIVER FUNCTION TEST ABNORMAL 14 0.0005
165 INSURANCE ISSUE 7 0.0005
166 INFUSION SITE INFECTION 1 0.0004
167 POST PROCEDURAL HAEMORRHAGE 5 0.0004
168 DIARRHOEA HAEMORRHAGIC 4 0.0004
169 SPLENOMEGALY 5 0.0004
170 SKIN ABRASION 2 0.0004
171 VIRAL INFECTION 14 0.0004
172 VARICELLA 1 0.0004
173 CHOLESTASIS 8 0.0004
174 EAR INFECTION 11 0.0004
175 HEPATOCELLULAR CARCINOMA 3 0.0004
176 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
177 HERNIA REPAIR 1 0.0004
178 PRODUCT USE COMPLAINT 6 0.0004
179 SKIN DISCOMFORT 1 0.0004
180 HEPATIC FAILURE 11 0.0004
181 HYPERKERATOSIS 2 0.0004
182 PRESCRIBED OVERDOSE 7 0.0004
183 TRANSAMINASES INCREASED 8 0.0004
184 ENDOTRACHEAL INTUBATION 1 0.0004
185 PREMATURE LABOUR 2 0.0004
186 RESPIRATORY SYMPTOM 1 0.0004
187 CARDIAC OPERATION 3 0.0003
188 VOMITING PROJECTILE 1 0.0003
189 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
190 ESCHERICHIA SEPSIS 1 0.0003
191 ADENOVIRUS INFECTION 1 0.0003
192 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
193 TOOTH DISCOLOURATION 1 0.0003
194 URINE ANALYSIS ABNORMAL 1 0.0003
195 DYSCHEZIA 1 0.0003
196 FRACTURE 6 0.0003
197 LISTLESS 1 0.0003
198 APPETITE DISORDER 2 0.0003
199 PEPTIC ULCER 1 0.0003
200 PRODUCT TASTE ABNORMAL 4 0.0003
201 DEFAECATION URGENCY 2 0.0003
202 JAUNDICE CHOLESTATIC 1 0.0003
203 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
204 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
205 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
206 INTENTIONAL UNDERDOSE 2 0.0003
207 LABORATORY TEST ABNORMAL 8 0.0003
208 WOUND HAEMORRHAGE 1 0.0003
209 MALNUTRITION 3 0.0003
210 POLYDIPSIA 1 0.0003
211 INTRACRANIAL ANEURYSM 1 0.0002
212 FRUSTRATION TOLERANCE DECREASED 2 0.0002
213 HEPATIC PAIN 1 0.0002
214 HEPATIC LESION 1 0.0002
215 HORDEOLUM 1 0.0002
216 ABDOMINAL ABSCESS 1 0.0002
217 LIVER DISORDER 10 0.0002
218 THERAPY INTERRUPTED 16 0.0002
219 HEAVY MENSTRUAL BLEEDING 2 0.0002
220 DEVELOPMENTAL DELAY 2 0.0002
221 VASCULAR DEVICE INFECTION 1 0.0002
222 URINE ABNORMALITY 1 0.0002
223 RHINORRHOEA 14 0.0002
224 PRODUCT DISTRIBUTION ISSUE 2 0.0002
225 RENAL FUNCTION TEST ABNORMAL 1 0.0002
226 HEPATIC FUNCTION ABNORMAL 8 0.0002
227 TIBIA FRACTURE 1 0.0002
228 SKIN TIGHTNESS 1 0.0002
229 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
230 INCREASED APPETITE 4 0.0002
231 RASH VESICULAR 1 0.0002
232 THERAPY CHANGE 2 0.0002
233 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
234 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
235 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
236 HYPERAMMONAEMIA 1 0.0002
237 FLUID INTAKE REDUCED 1 0.0002
238 PREMATURE BABY 6 0.0002
239 FEEDING DISORDER 4 0.0002
240 PETIT MAL EPILEPSY 1 0.0002
241 ANORECTAL DISCOMFORT 1 0.0002
242 ANAL ABSCESS 1 0.0002
243 NASOPHARYNGITIS 34 0.0002
244 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
245 PROTHROMBIN TIME PROLONGED 1 0.0002
246 GASTROENTERITIS VIRAL 3 0.0002
247 HEPATITIS CHOLESTATIC 1 0.0002
248 ILLNESS 17 0.0002
249 TREATMENT NONCOMPLIANCE 9 0.0002
250 INGUINAL HERNIA 1 0.0002
251 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
252 HAEMATOCHEZIA 9 0.0002
253 MIDDLE INSOMNIA 3 0.0002
254 HEPATIC CIRRHOSIS 3 0.0002
255 HAEMATEMESIS 4 0.0002
256 DIARRHOEA 101 0.0002
257 HAEMOGLOBIN ABNORMAL 1 0.0002
258 HEPATITIS ACUTE 1 0.0002
259 CORONAVIRUS INFECTION 1 0.0002
260 BLOOD CHOLESTEROL INCREASED 7 0.0002
261 CHOLECYSTITIS CHRONIC 1 0.0001
262 ABDOMINAL DISCOMFORT 25 0.0001
263 FREQUENT BOWEL MOVEMENTS 4 0.0001
264 ECCHYMOSIS 1 0.0001
265 ABDOMINAL PAIN UPPER 30 0.0001
266 RESPIRATION ABNORMAL 1 0.0001
267 AUTOIMMUNE HEPATITIS 1 0.0001
268 HYPERTRANSAMINASAEMIA 1 0.0001
269 BLOOD TEST ABNORMAL 2 0.0001
270 PAPULE 1 0.0001
271 SEASONAL ALLERGY 2 0.0001
272 HAND FRACTURE 1 0.0001
273 POOR QUALITY SLEEP 3 0.0001
274 ABDOMINAL PAIN 32 0.0001
275 OFF LABEL USE 120 0.0001
276 ACCIDENTAL OVERDOSE 5 0.0001
277 ASCITES 4 0.0001
278 ARTHROPOD BITE 1 0.0001
279 HYDRONEPHROSIS 1 0.0001
280 CHROMATURIA 3 0.0001
281 BOWEL MOVEMENT IRREGULARITY 1 0.0001
282 LIPASE INCREASED 1 0.0001
283 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
284 PULMONARY HAEMORRHAGE 1 0.0001
285 RENAL CYST 1 0.0001
286 PRODUCT DOSE OMISSION ISSUE 36 0.0001
287 LIVER INJURY 3 0.0001
288 CHOLELITHIASIS 4 0.0001
289 MENSTRUAL DISORDER 1 0.0001
290 COAGULOPATHY 2 0.0001
291 PRODUCT CONTAINER ISSUE 1 0.0001
292 MUSCLE STRAIN 1 0.0001
293 RESPIRATORY TRACT INFECTION 3 0.0001
294 URINE OUTPUT DECREASED 1 0.0001
295 OROPHARYNGEAL DISCOMFORT 1 0.0001
296 IRON DEFICIENCY ANAEMIA 1 0.0001
297 PERSONALITY CHANGE 1 0.0001
298 INFLUENZA 12 0.0001
299 WOUND 3 0.0001
300 HEPATIC ENCEPHALOPATHY 1 0.0001
301 APPENDICITIS 1 0.0001
302 BLOOD SODIUM DECREASED 2 0.0001
303 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
304 FLATULENCE 6 0.0001
305 POST PROCEDURAL COMPLICATION 2 0.0001
306 VITAMIN D DEFICIENCY 1 0.0001
307 HEPATOMEGALY 1 0.0001
308 LIGAMENT SPRAIN 1 0.0001
309 UPPER LIMB FRACTURE 2 0.0001
310 WEIGHT INCREASED 22 0.0001
311 SLUGGISHNESS 1 0.0001
312 EAR DISCOMFORT 1 0.0001
313 HYPERBILIRUBINAEMIA 1 0.0001
314 COUGH 27 0.0001
315 PULMONARY HYPERTENSION 2 0.0001
316 WEIGHT FLUCTUATION 1 0.0001
317 FULL BLOOD COUNT ABNORMAL 1 0.0001
318 RETCHING 2 0.0001
319 SKIN LACERATION 1 0.0001
320 GASTROINTESTINAL PAIN 1 0.0001
321 DENTAL CARIES 1 0.0001
322 RASH PAPULAR 2 0.0001
323 SNEEZING 2 0.0001
324 INTESTINAL PERFORATION 1 0.0001
325 VOMITING 41 0.0001
326 GASTRIC HAEMORRHAGE 1 0.0001
327 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
328 DECREASED APPETITE 20 0.0001
329 COVID-19 15 0.0001
330 NASAL CONGESTION 5 0.0001
331 PRODUCT PRESCRIBING ERROR 2 0.0001
332 CRYING 3 0.0001
333 ENCEPHALOPATHY 2 0.0001
334 GENERALISED OEDEMA 1 0.0001
335 EXPOSURE DURING PREGNANCY 5 0.0001
336 SECRETION DISCHARGE 1 0.0001
337 HEPATIC CYTOLYSIS 1 0.0001
338 SKIN ULCER 2 0.0001
339 HAEMATOMA 2 0.0001
340 PLATELET COUNT INCREASED 1 0.0001
341 NODULE 1 0.0001
342 HAEMORRHAGE 8 0.0001
343 SARS-COV-2 TEST POSITIVE 1 0.0001
344 ADVERSE REACTION 1 0.0001
345 SINUS CONGESTION 1 0.0001
346 GINGIVAL BLEEDING 1 0.0001
347 RESPIRATORY ARREST 2 0.0001
348 ORAL DISCOMFORT 1 0.0001
349 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
350 MASS 1 0.0001
351 INTENTIONAL DOSE OMISSION 2 0.0001
352 IMPAIRED QUALITY OF LIFE 1 0.0001
353 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
354 INSOMNIA 18 0.0001
355 SKIN HAEMORRHAGE 1 0.0001
356 PYREXIA 23 0.0001
357 SKIN DISCOLOURATION 3 0.0001
358 FEMUR FRACTURE 2 0.0001
359 PRODUCT USE ISSUE 12 0.0001
360 DRUG-INDUCED LIVER INJURY 2 0.0001
361 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
362 DRUG INEFFECTIVE 83 0.0001
363 RESPIRATORY TRACT CONGESTION 1 0.0001
364 ABSCESS 1 0.0001
365 BLOOD UREA INCREASED 1 0.0001
366 EYE PRURITUS 2 0.0001
367 PERICARDITIS 1 0.0001
368 CONDITION AGGRAVATED 18 0.0001
369 ECZEMA 3 0.0001
370 GASTROINTESTINAL DISORDER 5 0.0001
371 HEPATIC STEATOSIS 1 0.0001
372 EPISTAXIS 4 0.0001
373 PROTEINURIA 1 0.0001
374 SLEEP APNOEA SYNDROME 1 0.0001
375 LETHARGY 3 0.0001
376 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
377 HERNIA 1 0.0001
378 HAEMORRHOIDS 1 0.0001
379 CHOKING 1 0.0001
380 DISEASE PROGRESSION 6 0.0001
381 CONSTIPATION 11 0.0001
382 PRODUCT ADMINISTRATION ERROR 1 0.0000
383 SINUSITIS 5 0.0000
384 EATING DISORDER 1 0.0000
385 WEIGHT DECREASED 13 0.0000
386 SWELLING FACE 3 0.0000
387 MELAENA 1 0.0000
388 ORAL PAIN 1 0.0000
389 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
390 PRODUCT AVAILABILITY ISSUE 1 0.0000
391 SHOCK 1 0.0000
392 MUSCLE TWITCHING 1 0.0000
393 OROPHARYNGEAL PAIN 4 0.0000
394 PRODUCTIVE COUGH 2 0.0000
395 PRESYNCOPE 1 0.0000
396 DYSGEUSIA 3 0.0000
397 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
398 INCORRECT DOSE ADMINISTERED 9 0.0000
399 HYPOPHAGIA 1 0.0000
400 DEHYDRATION 5 0.0000
401 PAIN OF SKIN 1 0.0000
402 RASH PRURITIC 2 0.0000
403 OEDEMA 2 0.0000
404 SEPSIS 4 0.0000
405 HYPERSOMNIA 1 0.0000
406 DYSSTASIA 1 0.0000
407 IRRITABILITY 2 0.0000
408 BLOOD POTASSIUM DECREASED 1 0.0000
409 LACRIMATION INCREASED 1 0.0000
410 BONE DENSITY DECREASED 1 0.0000
411 HEAD INJURY 1 0.0000
412 MIGRAINE 3 0.0000
413 MOOD SWINGS 1 0.0000
414 HYPOTHYROIDISM 1 0.0000
415 LACTIC ACIDOSIS 1 0.0000
416 EYE DISORDER 1 0.0000
417 SKIN DISORDER 1 0.0000
418 DRY SKIN 4 0.0000
419 URTICARIA 5 0.0000
420 RASH 13 0.0000
421 ABDOMINAL DISTENSION 3 0.0000
422 SLEEP DISORDER 2 0.0000
423 CEREBRAL HAEMORRHAGE 1 0.0000
424 NAUSEA 22 0.0000
425 HYPERGLYCAEMIA 1 0.0000
426 RESTLESSNESS 1 0.0000
427 EYE SWELLING 1 0.0000
428 INTESTINAL OBSTRUCTION 1 0.0000
429 UNEVALUABLE EVENT 2 0.0000
430 ABNORMAL BEHAVIOUR 1 0.0000
431 NEUTROPHIL COUNT DECREASED 1 0.0000
432 CARDIAC ARREST 2 0.0000
433 RENAL IMPAIRMENT 2 0.0000
434 URINARY TRACT INFECTION 4 0.0000
435 BALANCE DISORDER 2 0.0000
436 VAGINAL HAEMORRHAGE 1 0.0000
437 MENTAL DISORDER 1 0.0000
438 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
439 MALAISE 10 0.0000
440 ADVERSE DRUG REACTION 2 0.0000
441 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
442 NEPHROLITHIASIS 1 0.0000
443 OCULAR HYPERAEMIA 1 0.0000
444 RASH ERYTHEMATOUS 1 0.0000
445 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
446 CONTUSION 2 0.0000
447 THERAPY CESSATION 1 0.0000
448 HAEMOGLOBIN DECREASED 2 0.0000
449 INFLAMMATION 1 0.0000
450 MUSCULOSKELETAL PAIN 1 0.0000
451 DEPRESSED MOOD 1 0.0000
452 PLATELET COUNT DECREASED 2 0.0000
453 PNEUMONIA 6 0.0000
454 MEDICATION ERROR 1 0.0000
455 ASTHMA 2 0.0000
456 MUSCULAR WEAKNESS 2 0.0000
457 THERAPEUTIC RESPONSE DECREASED 1 0.0000
458 ILL-DEFINED DISORDER 1 0.0000
459 DISCOMFORT 1 0.0000
460 AMNESIA 1 0.0000
461 RENAL FAILURE 2 0.0000
462 NEOPLASM MALIGNANT 1 0.0000
463 SOMNOLENCE 3 0.0000
464 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
465 OVERDOSE 3 0.0000
466 INFECTION 2 0.0000
467 UNDERDOSE 1 0.0000
468 AGITATION 1 0.0000
469 DEPRESSION 3 0.0000
470 HOSPITALISATION 2 0.0000
471 PARAESTHESIA 2 0.0000
472 CARDIAC FAILURE 1 0.0000
473 THROMBOSIS 1 0.0000
474 INFLUENZA LIKE ILLNESS 1 0.0000
475 SKIN EXFOLIATION 1 0.0000
476 PRODUCT STORAGE ERROR 1 0.0000
477 INTENTIONAL PRODUCT MISUSE 1 0.0000
478 MUSCULOSKELETAL STIFFNESS 1 0.0000
479 HEADACHE 7 0.0000
480 MUSCLE SPASMS 2 0.0000
481 CARDIAC DISORDER 1 0.0000
482 ANAEMIA 2 0.0000
483 DRUG INTOLERANCE 1 0.0000
484 FATIGUE 8 0.0000
485 PAIN IN EXTREMITY 3 0.0000
486 DIZZINESS 5 0.0000
487 SYNCOPE 1 0.0000
488 PAIN 6 0.0000
489 THROMBOCYTOPENIA 1 0.0000
490 OEDEMA PERIPHERAL 1 0.0000
491 LOSS OF CONSCIOUSNESS 1 0.0000
492 PRODUCT QUALITY ISSUE 1 0.0000
493 ANXIETY 2 0.0000
494 DEATH 6 0.0000
495 ACUTE KIDNEY INJURY 1 0.0000
496 PERIPHERAL SWELLING 1 0.0000
497 FALL 2 0.0000
498 TOXICITY TO VARIOUS AGENTS 1 0.0000
499 CHEST PAIN 1 0.0000
500 HYPERSENSITIVITY 1 0.0000
501 ASTHENIA 2 0.0000
502 GAIT DISTURBANCE 1 0.0000
503 ALOPECIA 1 0.0000
504 ARTHRALGIA 2 0.0000
505 FEELING ABNORMAL 1 0.0000
506 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
507 DYSPNOEA 1 0.0000